NeuroSense Therapeutics News

D: Filing D

Apr 25 16:08 ET

NeuroSense Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ariel Gordon.(6.9%)

Feb 13 13:25 ET

NeuroSense Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alon Ben-Noon(19.98%)

Feb 13 10:19 ET

NeuroSense Therapeutics | D: Filing D

Jul 5, 2023 14:09 ET

NeuroSense Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alon Ben-Noon(25.77%)

Apr 5, 2023 08:02 ET

NeuroSense Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ariel Gordon.(8.92%)

Mar 15, 2023 15:42 ET

NeuroSense Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-E Europe Limited(0%)

Mar 15, 2023 15:32 ET

NeuroSense Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Real Property International Limited(3.84%)

Mar 15, 2023 14:43 ET

NeuroSense Therapeutics | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Dec 30, 2021 11:13 ET

NeuroSense Therapeutics | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Dec 23, 2021 17:03 ET

NeuroSense Therapeutics | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Dec 20, 2021 16:40 ET